Related Experiment Video
Updated: Sep 7, 2026

Programmed Electrical Stimulation in Mice
Published on: May 27, 2010
Closed-loop drug infusion for control of heart-rate trajectory in pharmacological stress tests
1Gensia, Inc., San Diego, CA 92121, USA. valcke@gensia.com
Insights
A new system using arbutamine automates pharmacological stress testing for coronary artery disease (CAD) diagnosis. This closed-loop algorithm effectively controls heart rate, offering a safer and more efficient diagnostic method for cardiologists.
Area of Science:
- Cardiology
- Pharmacology
- Biomedical Engineering
Background:
- Coronary artery disease (CAD) diagnosis is crucial in cardiology.
- Pharmacological stress testing is an emerging alternative to exercise stress testing (ETT).
- A novel device-drug system for CAD diagnosis has been developed.
Purpose of the Study:
- To develop and evaluate a closed-loop control algorithm for arbutamine infusion.
- To create a pharmacodynamic (PD) model of heart rate (HR) response to arbutamine.
- To assess the safety and efficacy of automated arbutamine delivery for stress testing.
Main Methods:
- Development of a closed-loop control algorithm for intravenous arbutamine delivery.
- Creation of a PD model to predict HR response to arbutamine.
- Estimation of model parameters using clinical data from volunteers and patients.
- Testing the algorithm via simulations, animal studies, and human clinical trials.
Main Results:
- The control algorithm successfully managed HR increase along a predetermined trajectory.
- Clinical trials demonstrated the algorithm's effectiveness in controlling arbutamine infusion.
- Simulations, animal, and human trials validated the algorithm's performance.
Conclusions:
- The developed algorithm enables precise control of arbutamine infusion for stress testing.
- Automated drug delivery offers an efficient, effective, and safe method for pharmacological stress tests.
- This system enhances the diagnostic capabilities for cardiologists managing CAD patients.
Abstract:
The diagnosis of coronary artery disease (CAD) is an important task in the management of cardiology patients. Recently, the use of pharmacological stress testing has become available as an alternative to exercise stress testing (ETT). A new system (device-drug combination) was developed specifically for the diagnosis of coronary artery disease. The system uses a novel catecholamine, arbutamine, which is infused intravenously to increase heart rate (HR) and cardiac contractility in order to evoke signs of ischemia. The development of a closed-loop control algorithm for the delivery of this drug and a pharmacodynamic (PD) model representing the HR response to arbutamine infusions are presented. Model parameters are estimated from clinical data on normal volunteers and patients. Based on this mathematical model, a rule-based control algorithm is designed. The structure of the control algorithm is discussed and testing of the algorithm based on simulations and animal and human trials are summarized. Results from clinical trials shows that the algorithm controls the HR increase according to a selected trajectory. The automated delivery of the drug can provide the cardiologist with an efficient, effective, and safe method for administering a pharmacological stress test.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Pathophysiology of Cardiac Performance
Heart Failure Drugs: Inotropic Agents
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management

